Symbols / OFIX Stock $12.01 -2.28% Orthofix Medical Inc.

Healthcare • Medical Devices • United States • NMS
OFIX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Massimo Calafiore
Exch · Country NMS · United States
Market Cap 485.46M
Enterprise Value 627.44M
Income -60.01M
Sales 825.37M
FCF (ttm) 22.02M
Book/sh 11.30
Cash/sh 2.98
Employees 1,605
Insider 10d —
IPO Apr 24, 1992
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 14.05
PEG 8.78
P/S 0.59
P/B 1.06
P/C —
EV/EBITDA 36.90
EV/Sales 0.76
Quick Ratio 1.60
Current Ratio 2.87
Debt/Eq 60.26
LT Debt/Eq —
EPS (ttm) -1.50
EPS next Y 0.85
EPS Growth —
Revenue Growth 1.60%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-04
Earnings (prior) 2026-05-05
ROA -3.25%
ROE -13.43%
ROIC —
Gross Margin 71.01%
Oper. Margin -6.75%
Profit Margin -7.27%
Shs Outstand 40.42M
Shs Float 39.83M
Insider Own 1.86%
Instit Own 91.10%
Short Float 3.47%
Short Ratio 5.35
Short Interest 1.24M
52W High 16.99
vs 52W High -29.31%
52W Low 10.24
vs 52W Low 17.29%
Beta 0.79
Impl. Vol. —
Rel Volume 0.75
Avg Volume 297.02K
Volume 221.53K
Target (mean) $17.25
Tgt Median $17.50
Tgt Low $14.00
Tgt High $20.00
# Analysts 4
Recom Buy
Prev Close $12.29
Price $12.01
Change -2.28%
About

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$17.25
Mean price target
2. Current target
$12.01
Latest analyst target
3. DCF / Fair value
$9.81
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$12.01
Low
$14.00
High
$20.00
Mean
$17.25

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-10 main Barrington Research Outperform → Outperform $17
2026-03-09 main Stifel Buy → Buy $18
2026-02-26 main Canaccord Genuity Buy → Buy $20
2026-02-25 main Barrington Research Outperform → Outperform $17
2026-02-17 main Barrington Research Outperform → Outperform $18
2026-01-27 init TD Cowen — → Hold $14
2025-11-05 main Barrington Research Outperform → Outperform $18
2025-10-23 main Barrington Research Outperform → Outperform $17
2025-09-23 main Barrington Research Outperform → Outperform $17
2025-06-23 init Barrington Research — → Outperform $16
2025-06-06 reit JMP Securities Market Perform → Market Perform —
2025-02-26 main Canaccord Genuity Buy → Buy $24
2025-02-26 reit Roth MKM Buy → Buy $22
2025-01-22 init Canaccord Genuity — → Buy $24
2024-11-08 reit Roth MKM Buy → Buy $22
2024-11-08 up Stifel Hold → Buy $24
2024-05-08 up Roth MKM Neutral → Buy $20
2024-04-22 reit JMP Securities — → Market Perform —
2024-03-07 main Roth MKM Neutral → Neutral $15
2023-10-20 init Roth MKM — → Neutral $12
News
RSS: Latest OFIX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-07 HENNEMAN JOHN BELL III Director — 5,000 $12.26 $61,295
2026-05-07 ENGINE CAPITAL MANAGEMENT, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 184,896 $11.99 $2,232,927
2026-04-16 CEDRON JORGE ANDRES Officer — 3,743 $12.82 $47,985
2026-03-17 VITALE LUCAS S Chief Operating Officer — 4,269 $11.92 $50,886
2026-03-10 CAPPS VICKIE LYNN Director — 5,000 $12.44 $62,324
2026-03-05 CEDRON JORGE ANDRES Officer — 2,775 $12.55 $35,342
2026-03-05 MCPHERRON AVIVA Officer — 2,559 $12.55 $32,591
2026-03-05 ANDREWS JULIE Chief Financial Officer — 4,788 $12.55 $60,980
2026-03-05 FISHER PATRICK G Officer — 1,536 $12.55 $19,562
2026-03-05 VITALE LUCAS S Chief Operating Officer — 2,312 $12.55 $29,445
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
822.31
+2.85%
799.49
+7.08%
746.64
+62.06%
460.71
Operating Revenue
822.31
+2.85%
799.49
+7.08%
746.64
+62.06%
460.71
Cost Of Revenue
256.30
+1.06%
253.61
-2.60%
260.37
+110.75%
123.54
Reconciled Cost Of Revenue
201.45
+3.26%
195.08
-10.19%
217.22
+117.95%
99.67
Gross Profit
566.02
+3.69%
545.88
+12.26%
486.27
+44.22%
337.17
Operating Expense
648.59
+4.01%
623.60
-0.71%
628.03
+71.58%
366.04
Research And Development
65.85
-10.59%
73.64
-8.21%
80.23
+63.52%
49.06
Selling General And Administration
554.33
+4.09%
532.52
+0.40%
530.39
+71.77%
308.78
Selling And Marketing Expense
—
—
385.74
+68.58%
228.81
General And Administrative Expense
—
—
144.66
+80.90%
79.97
Other Gand A
—
—
144.66
+80.90%
79.97
Total Expenses
904.88
+3.15%
877.21
-1.26%
888.40
+81.46%
489.58
Operating Income
-82.57
-6.24%
-77.72
+45.18%
-141.76
-391.07%
-28.87
Total Operating Income As Reported
-81.43
+3.77%
-84.62
+39.17%
-139.11
-948.46%
-13.27
EBITDA
9.93
+154.33%
-18.28
+77.00%
-79.49
-607.68%
15.66
Normalized EBITDA
8.79
+177.25%
-11.38
+86.14%
-82.14
-144201.75%
0.06
Reconciled Depreciation
83.25
+9.60%
75.96
+25.43%
60.56
+88.81%
32.08
EBIT
-73.32
+22.20%
-94.24
+32.71%
-140.05
-753.01%
-16.42
Total Unusual Items
1.14
+116.52%
-6.90
-360.28%
2.65
-83.01%
15.60
Total Unusual Items Excluding Goodwill
1.14
+116.52%
-6.90
-360.28%
2.65
-83.01%
15.60
Special Income Charges
1.14
+116.52%
-6.90
-360.28%
2.65
-83.01%
15.60
Other Special Charges
—
—
0.05
-96.94%
1.60
Impairment Of Capital Assets
—
—
0.00
0.00
Restructuring And Mergern Acquisition
-1.14
-116.52%
6.90
+355.56%
-2.70
+84.30%
-17.20
Net Income
-92.19
+26.83%
-126.00
+16.78%
-151.40
-666.60%
-19.75
Pretax Income
-90.81
+26.69%
-123.88
+16.68%
-148.68
-739.71%
-17.71
Net Non Operating Interest Income Expense
-17.49
+40.98%
-29.63
-243.31%
-8.63
-570.11%
-1.29
Interest Expense Non Operating
17.49
-40.98%
29.63
+243.31%
8.63
+570.11%
1.29
Net Interest Income
-17.49
+40.98%
-29.63
-243.31%
-8.63
-570.11%
-1.29
Interest Expense
17.49
-40.98%
29.63
+243.31%
8.63
+570.11%
1.29
Other Income Expense
9.25
+155.95%
-16.52
-1064.68%
1.71
-86.24%
12.45
Other Non Operating Income Expenses
8.11
+184.22%
-9.62
-926.12%
-0.94
+70.22%
-3.15
Tax Provision
1.38
-34.87%
2.12
-21.87%
2.72
+32.94%
2.04
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.24
+116.52%
-1.45
-360.28%
0.56
-83.01%
3.28
Net Income Including Noncontrolling Interests
-92.19
+26.83%
-126.00
+16.78%
-151.40
-666.60%
-19.75
Net Income From Continuing Operation Net Minority Interest
-92.19
+26.83%
-126.00
+16.78%
-151.40
-666.60%
-19.75
Net Income From Continuing And Discontinued Operation
-92.19
+26.83%
-126.00
+16.78%
-151.40
-666.60%
-19.75
Net Income Continuous Operations
-92.19
+26.83%
-126.00
+16.78%
-151.40
-666.60%
-19.75
Normalized Income
-93.09
+22.77%
-120.55
+21.46%
-153.49
-378.56%
-32.07
Net Income Common Stockholders
-92.19
+26.83%
-126.00
+16.78%
-151.40
-666.60%
-19.75
Diluted EPS
-2.33
+29.39%
-3.30
+19.90%
-4.12
-320.41%
-0.98
Basic EPS
-2.33
+29.39%
-3.30
+19.90%
-4.12
-320.41%
-0.98
Basic Average Shares
39.60
+3.94%
38.10
+3.73%
36.73
+82.73%
20.10
Diluted Average Shares
39.60
+3.94%
38.10
+3.73%
36.73
+82.73%
20.10
Diluted NI Availto Com Stockholders
-92.19
+26.83%
-126.00
+16.78%
-151.40
-666.60%
-19.75
Amortization
28.41
+62.93%
17.44
+0.16%
17.41
+112.40%
8.20
Amortization Of Intangibles Income Statement
28.41
+62.93%
17.44
+0.16%
17.41
+112.40%
8.20
Depreciation Amortization Depletion Income Statement
28.41
+62.93%
17.44
+0.16%
17.41
+112.40%
8.20
Depreciation And Amortization In Income Statement
28.41
+62.93%
17.44
+0.16%
17.41
+112.40%
8.20
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
850.65
-4.77%
893.29
-3.46%
925.32
+101.76%
458.63
Current Assets
416.85
-3.79%
433.29
+3.05%
420.44
+64.24%
255.99
Cash Cash Equivalents And Short Term Investments
82.03
-1.46%
83.24
+151.42%
33.11
-34.70%
50.70
Cash And Cash Equivalents
82.03
-1.46%
83.24
+151.42%
33.11
-34.70%
50.70
Receivables
135.75
+0.77%
134.71
+5.16%
128.10
+54.60%
82.86
Accounts Receivable
135.75
+0.77%
134.71
+5.16%
128.10
+54.60%
82.86
Gross Accounts Receivable
144.05
+1.35%
142.13
+5.10%
135.23
+51.47%
89.28
Allowance For Doubtful Accounts Receivable
-8.31
-12.00%
-7.42
-4.04%
-7.13
-11.08%
-6.42
Inventory
172.32
-9.04%
189.45
-14.73%
222.17
+121.83%
100.15
Raw Materials
22.86
-15.88%
27.18
-4.26%
28.39
+66.66%
17.04
Work In Process
63.26
+11.13%
56.92
+6.37%
53.51
+178.08%
19.24
Finished Goods
86.20
-18.18%
105.35
-24.89%
140.27
+119.60%
63.87
Prepaid Assets
—
—
—
—
Restricted Cash
3.09
+23.60%
2.50
-46.24%
4.65
0.00
Other Current Assets
23.67
+1.22%
23.38
-27.88%
32.42
+45.50%
22.28
Total Non Current Assets
433.80
-5.70%
460.01
-8.89%
504.87
+149.15%
202.64
Net PPE
129.40
-7.44%
139.80
-12.11%
159.06
+173.16%
58.23
Gross PPE
380.14
+7.98%
352.05
+1.25%
347.69
+57.16%
221.22
Accumulated Depreciation
-250.74
-18.14%
-212.24
-12.52%
-188.62
-15.72%
-163.00
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
4.40
+13.58%
3.87
-5.58%
4.10
+6.10%
3.87
Machinery Furniture Equipment
138.69
+8.60%
127.71
+2.74%
124.30
+28.20%
96.96
Construction In Progress
23.23
+2.39%
22.69
-45.65%
41.75
+824.72%
4.51
Other Properties
213.81
+8.11%
197.77
+11.40%
177.53
+53.20%
115.88
Goodwill And Other Intangible Assets
267.70
-8.86%
293.74
-5.98%
312.42
+163.19%
118.70
Goodwill
194.93
+0.00%
194.93
+0.00%
194.93
+173.33%
71.32
Other Intangible Assets
72.77
-26.35%
98.80
-15.91%
117.49
+147.93%
47.39
Non Current Deferred Assets
—
—
—
—
Non Current Deferred Taxes Assets
—
—
—
—
Other Non Current Assets
36.70
+38.67%
26.47
-20.73%
33.39
+29.89%
25.70
Total Liabilities Net Minority Interest
400.61
+2.68%
390.17
+19.47%
326.58
+168.20%
121.77
Current Liabilities
170.48
+1.10%
168.63
+2.06%
165.22
+97.58%
83.62
Payables And Accrued Expenses
162.21
+3.48%
156.75
-1.28%
158.79
+95.23%
81.33
Payables
71.22
+7.09%
66.50
-9.01%
73.09
+88.30%
38.82
Accounts Payable
58.39
+19.65%
48.80
-16.37%
58.36
+111.45%
27.60
Other Payable
9.22
-0.72%
9.29
+29.87%
7.15
+54.34%
4.63
Current Accrued Expenses
90.99
+0.82%
90.25
+5.31%
85.69
+101.56%
42.52
Total Tax Payable
3.61
-57.11%
8.41
+10.93%
7.58
+15.17%
6.59
Current Debt And Capital Lease Obligation
3.98
-16.62%
4.78
-12.09%
5.43
+137.34%
2.29
Current Debt
—
—
1.25
—
Other Current Borrowings
—
—
1.25
—
Current Capital Lease Obligation
3.98
-16.62%
4.78
+14.17%
4.18
+82.75%
2.29
Other Current Liabilities
4.29
-39.58%
7.10
+610.00%
1.00
+0.00%
1.00
Total Non Current Liabilities Net Minority Interest
230.13
+3.88%
221.54
+37.30%
161.36
+323.02%
38.15
Long Term Debt And Capital Lease Obligation
174.45
-0.23%
174.85
+56.62%
111.64
+480.27%
19.24
Long Term Debt
157.39
+0.24%
157.01
+68.64%
93.11
—
Long Term Capital Lease Obligation
17.06
-4.35%
17.84
-3.76%
18.53
-3.67%
19.24
Other Non Current Liabilities
55.68
+19.24%
46.69
-6.10%
49.72
+163.00%
18.91
Stockholders Equity
450.04
-10.55%
503.12
-15.97%
598.73
+77.74%
336.86
Common Stock Equity
450.04
-10.55%
503.12
-15.97%
598.73
+77.74%
336.86
Capital Stock
3.98
+3.48%
3.85
+3.55%
3.72
+84.38%
2.02
Common Stock
3.98
+3.48%
3.85
+3.55%
3.72
+84.38%
2.02
Share Issued
39.83
+3.50%
38.49
+3.55%
37.16
+84.33%
20.16
Ordinary Shares Number
39.83
+3.50%
38.49
+3.55%
37.16
+84.33%
20.16
Additional Paid In Capital
813.77
+4.37%
779.72
+4.46%
746.45
+122.84%
334.97
Retained Earnings
-368.33
-33.39%
-276.14
-83.92%
-150.14
-12101.92%
1.25
Gains Losses Not Affecting Retained Earnings
0.62
+114.37%
-4.30
-232.71%
-1.29
+6.03%
-1.38
Other Equity Adjustments
0.62
+114.37%
-4.30
-232.71%
-1.29
+6.03%
-1.38
Total Equity Gross Minority Interest
450.04
-10.55%
503.12
-15.97%
598.73
+77.74%
336.86
Total Capitalization
607.43
-7.98%
660.14
-4.58%
691.84
+105.38%
336.86
Working Capital
246.37
-6.91%
264.66
+3.70%
255.22
+48.07%
172.37
Invested Capital
607.43
-7.98%
660.14
-4.75%
693.09
+105.75%
336.86
Total Debt
178.44
-0.66%
179.63
+53.43%
117.07
+443.80%
21.53
Net Debt
75.37
+2.15%
73.78
+20.45%
61.25
—
Capital Lease Obligations
21.04
-6.94%
22.61
-0.46%
22.72
+5.52%
21.53
Net Tangible Assets
182.34
-12.92%
209.39
-26.87%
286.31
+31.24%
218.16
Tangible Book Value
182.34
-12.92%
209.39
-26.87%
286.31
+31.24%
218.16
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
33.35
+29.30%
25.79
+156.37%
-45.75
-296.54%
-11.54
Cash Flow From Continuing Operating Activities
33.35
+29.30%
25.79
+156.37%
-45.75
-296.54%
-11.54
Net Income From Continuing Operations
-92.19
+26.83%
-126.00
+16.78%
-151.40
-666.60%
-19.75
Depreciation Amortization Depletion
83.25
+9.60%
75.96
+25.43%
60.56
+88.81%
32.08
Depreciation
83.25
+9.60%
75.96
+25.43%
60.56
+88.81%
32.08
Amortization Cash Flow
—
19.00
+0.53%
18.90
+101.06%
9.40
Depreciation And Amortization
83.25
+9.60%
75.96
+25.43%
60.56
+88.81%
32.08
Amortization Of Intangibles
—
19.00
+0.53%
18.90
+101.06%
9.40
Other Non Cash Items
-0.69
-102.27%
30.46
-5.00%
32.06
+282.66%
-17.55
Stock Based Compensation
28.69
-11.61%
32.45
-9.11%
35.71
+93.61%
18.44
Provisionand Write Offof Assets
33.08
+17.08%
28.25
-0.50%
28.40
+67.02%
17.00
Asset Impairment Charge
—
—
0.00
0.00
Deferred Tax
0.22
-88.16%
1.88
+225.22%
0.58
+84.39%
0.31
Deferred Income Tax
0.22
-88.16%
1.88
+225.22%
0.58
+84.39%
0.31
Operating Gains Losses
1.14
-43.70%
2.02
-11.96%
2.30
+11.00%
2.07
Gain Loss On Sale Of PPE
1.14
-43.70%
2.02
-11.96%
2.30
+11.00%
2.07
Change In Working Capital
-20.16
-4.71%
-19.25
+64.33%
-53.96
-22.25%
-44.14
Change In Receivables
-1.58
+83.38%
-9.53
+8.50%
-10.41
-54.58%
-6.74
Changes In Account Receivables
-1.58
+83.38%
-9.53
+8.50%
-10.41
-54.58%
-6.74
Change In Inventory
-10.75
-93.80%
-5.55
+90.45%
-58.05
-75.70%
-33.04
Change In Prepaid Assets
-3.93
-762.06%
0.59
-66.31%
1.76
+301.37%
-0.87
Change In Payables And Accrued Expense
2.60
+146.65%
-5.57
-164.46%
8.64
+278.70%
2.28
Change In Payable
2.60
+146.65%
-5.57
-164.46%
8.64
+278.70%
2.28
Change In Account Payable
2.60
+146.65%
-5.57
-164.46%
8.64
+278.70%
2.28
Change In Other Working Capital
-4.23
+51.52%
-8.73
-32425.93%
0.03
+100.42%
-6.40
Change In Other Current Liabilities
-2.27
-123.81%
9.53
+134.14%
4.07
+548.96%
0.63
Investing Cash Flow
-34.60
-25.45%
-27.58
+16.75%
-33.13
-35.04%
-24.53
Cash Flow From Continuing Investing Activities
-34.60
-25.45%
-27.58
+16.75%
-33.13
-35.04%
-24.53
Capital Expenditure
-34.63
+0.72%
-34.88
+43.79%
-62.05
-167.92%
-23.16
Capital Expenditure Reported
-34.63
+0.72%
-34.88
+43.79%
-62.05
-167.92%
-23.16
Net Investment Purchase And Sale
0.00
-100.00%
7.40
0.00
-100.00%
0.13
Purchase Of Investment
—
—
0.00
0.00
Sale Of Investment
0.00
-100.00%
7.40
0.00
-100.00%
0.13
Net Business Purchase And Sale
0.00
0.00
-100.00%
29.42
+2061.27%
-1.50
Purchase Of Business
—
0.00
0.00
+100.00%
-1.50
Net Other Investing Changes
0.03
+128.00%
-0.10
+80.00%
-0.50
+63.61%
-1.37
Financing Cash Flow
-0.79
-101.55%
50.71
-22.37%
65.32
+83846.15%
-0.08
Cash Flow From Continuing Financing Activities
-0.79
-101.55%
50.71
-22.37%
65.32
+83846.15%
-0.08
Net Issuance Payments Of Debt
-0.76
-101.40%
54.39
-19.95%
67.95
+2719.47%
-2.59
Issuance Of Debt
0.00
-100.00%
197.60
+13.24%
174.50
0.00
Repayment Of Debt
-0.76
+99.47%
-143.21
-34.40%
-106.55
-4007.59%
-2.59
Long Term Debt Issuance
0.00
-100.00%
197.60
+13.24%
174.50
0.00
Long Term Debt Payments
-0.76
+99.47%
-143.21
-34.40%
-106.55
-4007.59%
-2.59
Net Long Term Debt Issuance
-0.76
-101.40%
54.39
-19.95%
67.95
+2719.47%
-2.59
Short Term Debt Issuance
—
—
—
—
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
5.93
-5.24%
6.26
+22.04%
5.13
+18.22%
4.34
Net Other Financing Charges
-5.95
+40.12%
-9.94
-28.22%
-7.75
-325.81%
-1.82
Changes In Cash
-2.04
-104.16%
48.92
+460.71%
-13.56
+62.48%
-36.15
Effect Of Exchange Rate Changes
1.41
+250.75%
-0.94
-251.53%
0.62
+162.09%
-1.00
Beginning Cash Position
85.74
+127.08%
37.76
-25.53%
50.70
-42.29%
87.85
End Cash Position
85.11
-0.73%
85.74
+127.08%
37.76
-25.53%
50.70
Free Cash Flow
-1.28
+85.92%
-9.09
+91.57%
-107.80
-210.69%
-34.70
Common Stock Issuance
5.93
-5.24%
6.26
+22.04%
5.13
+18.22%
4.34
Issuance Of Capital Stock
5.93
-5.24%
6.26
+22.04%
5.13
+18.22%
4.34
Sale Of Business
0.00
0.00
-100.00%
29.42
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category